ALXO FY 2021 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$112M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$84M

Net Income

-$83M

EPS (Diluted)

$-2.07

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$73M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$380M

Total Liabilities

$17M

Stockholders' Equity

$363M

Cash & Equivalents

$364M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	$0	$107,000	-100.0%
Operating Income	-$84M	-$44M	-91.4%
Net Income	-$83M	-$46M	-82.5%